According to @Ultra_Calls, $WGRX is currently undervalued and may replicate a move similar to $MOBX. The stock is linked to a disruption in the $600 billion prescription drug industry, suggesting significant potential for growth. Traders are advised to monitor $WGRX closely along with related small-cap stocks in the pharmaceutical sector.